Inclusion Criteria: Provider  Licensed provider actively practicing medicine at a UC Health clinic that routinely provides medical treatment for patients with type 2 diabetes  Inclusion Criteria: Patient  Patients receiving care at a UC Health system Age 40 years or older Type 2 Diabetes Eligible for (per drug label/guidelines) at least one of the following classes: SGLT2i, PCSK9i, GLP-1 RA but not currently prescribed any of these classes of drugs Able to provide consent  Exclusion Criteria:  Use of SGLT2i or GLP1RA within the 3 months prior to enrollment Systemic Lupus Erythematous (SLE)* Pregnancy (as determined by self report) Intolerance or contraindication for use of both GLP1RA and SGLT2i  History of, an active, or untreated malignancy, in remission from a clinically significant malignancy (other than basal or squamous cell skin cancer, in situ carcinomas of the cervix, or in situ prostate cancer) for less than 5 years prior to, or are receiving or planning to receive therapy for cancer, at screening  Samples provided by patients with SLE may fail to produce results or may produce inaccurate results because autoantibodies in the patient plasma may interact with the DNA-based reagents used in the assay